STERIS plc (STE) is well-poised to grow in the coming quarters, backed by its advancements in the healthcare and pharmaceutical industries. The widespread market acceptance of its diverse offerings is driving growth in the Healthcare business.  The company is also solvent enough to meet its near-term debt obligations. However, macroeconomic constraints challenge STERIS’ operations, while competitive disadvantages remain a concern.In the past year, shares of this Zacks Rank #3 (Hold) company have rallied 14% ...